<?xml version="1.0" encoding="UTF-8"?>
<ref id="B72-pharmaceuticals-12-00147">
 <label>72.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Sadewasser</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Paki</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Eichelbaum</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Bogdanow</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Saenger</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Budt</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Lesch</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Hinz</surname>
    <given-names>K.P.</given-names>
   </name>
   <name>
    <surname>Herrmann</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Meyer</surname>
    <given-names>T.F.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Quantitative Proteomic Approach Identifies Vpr Binding Protein as Novel Host Factor Supporting Influenza A Virus Infections in Human Cells</article-title>
  <source>Mol. Cell. Proteom.</source>
  <year>2017</year>
  <volume>16</volume>
  <fpage>728</fpage>
  <lpage>742</lpage>
  <pub-id pub-id-type="doi">10.1074/mcp.M116.065904</pub-id>
 </element-citation>
</ref>
